Lazar FINN

Lazar Partners is a New York-founded healthcare communications and investor relations agency focused on medical device, biotech, specialty pharma, digital health, and health technology clients. The firm was founded in 2001 by Fern Lazar and built a specialization in high-science communications, including public relations, investor relations, scientific writing, patient communications, and clinical trial awareness. In September 2019, Lazar Partners was acquired by FINN Partners and has since operated as "LAZAR, a Finn Partners Company" or Lazar/FINN within FINN's Global Health Practice. It is not a drug developer, manufacturer, or therapeutic platform company; rather, it provides strategic communications services to life sciences and healthcare companies. The business appears to remain active as part of FINN Partners.